Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate

Urology. 2000 Feb;55(2):169-74. doi: 10.1016/s0090-4295(99)00419-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / radiotherapy*
  • Androgen Antagonists / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Humans
  • Male
  • Patient Selection
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy*
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Time Factors

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal